FW: Weekly Digest #606 07 January 2022

4 views
Skip to first unread message

Catherine Muyawala

unread,
Jan 7, 2022, 8:11:52 AMJan 7
to bidini...@googlegroups.com

 

Weekly Digest

Issue: 606

7th January 2022

View online

 

This week

New forum posts

HLN updates COVID-19 vaccine support in its Award Winning ICE Open Source Immunization Forecaster

ICE LogoOn December 22, 2021, HLN released a new version (v1.33.1) of the Immunization Calculation Engine (ICE) in support of updates to the COVID-19 vaccine. ICE is a state-of-the-art open source software system that provides clinical decision support for immunizations for use in Immunization Information Systems (IIS), Electronic Health Record (EHR), and Personal Health Record (PHR) Systems.

Version 1.33.1 includes the following additions and updates. Please see the Release Notes for details.

  • COVID-19 Booster Dose rules - Updated and added additional rules for patients who completed Pfizer 2-dose series, Moderna 2-dose series, Janssen 1-dose series, Pfizer COVID-19 Child (5-17) 2-dose series, COVID-19 vaccine series not authorized by the FDA, but authorized by the WHO, or a COVID-19 vaccine series not authorized by the FDA or WHO, but is an active COVID-19 vaccine candidate as part of a U.S.-based clinical trial of a COVID-19 vaccine. 
    • Booster Dose Minimum Age has been updated to 16 years to support new CDC recommendation that 16-17 year olds "may" receive a Pfizer booster.
  • COVID-19 Additional Dose rules - Updated and added additional rules for patients who completed Pfizer 2-dose series, Moderna 2-dose series, Janssen 1-dose series, Pfizer COVID-19 Child (5-17) 2-dose series, COVID-19 vaccine series not authorized by the FDA, but authorized by the WHO, or a COVID-19 vaccine series not authorized by the FDA or WHO, but is an active COVID-19 vaccine candidate as part of a U.S.-based clinical trial of a COVID-19 vaccine. 
  • New COVID-19 vaccine (CVX 217) - Added support and logic
    • Note - CVX 217 is a new Pfizer formulation for ages 12+ under EUA; can be used in the same way as CVX 208
  • Pfizer 2-dose series
    • Updated Absolute Minimum Intervals between Dose 1 and Dose 2
  • Moderna 2-dose series 
    • Updated Absolute Minimum Intervals between Dose 1 and Dose 2
    • Updated Absolute Minimum Age for Dose 1
    • Updated Absolute Minimum Age for Dose 2
    • Updated Minimum Age for Dose 2
    • Updated Routine Age for Dose 2

This release includes an important security update. We strongly recommend that all users and service providers update their running instances of ICE to version 1.33.1 as soon as possible. Each new release of ICE contains important forecaster logic updates and bug fixes.

Plans for COVID-19 Support in ICE

Once a vaccine has been approved for use by the FDA (either Expanded Access, EUA, or full licensure), the Advisory Committee on Immunization Practices (ACIP) will hold an emergency meeting and publish recommendations in a very quick time frame (i.e., days). HLN intends to release a version of ICE that includes updated COVID-19 forecasting as early as possible. The initial release will contain COVID-19 logic that is known at the time of the release. As additional, relevant information on COVID-19 becomes available from official sources, HLN will continue to release additional versions of ICE, at appropriate times.

If you have any questions, comments or suggestions, please e-mail us at i...@hln.com.

Lux Phatak

28/12/2021

Immunization information systems & coverage monitoring

[Vaccine management] [Immunization information systems] [Interoperability] [COVID-19]</

 

 

 

 

 

New resources

 

Projecto VxData Síntese dos achados dos Países

Author: JSI,Sonder Design Collective

Published: 2021

Link: View

 

Étude VxData Insights: Rapport Transnational

Author: JSI,Sonder Design Collective

Published: 2021

Link: View

 

VxData Insights Cross-Country Report

Author: JSI,Sonder Design Collective

Published: 2021

Link: View

 

Equité dans la Chaîne d'approvisionnement des vaccins

Author: Momentum,VillageReach

Published: 2021

Link: View

 

Equity in Immunization Supply Chain

Author: Momentum,VillageReach

Published: 2021

Link: View

 

WHO PQS Immunization Cold Chain Manufacturer Consultation

Author: WHO PQS

Published: 2020

Link: View

 

WHO PQS Immunization Cold Chain Manufacturer Consultation

Author:

Published: 2020

Link: View

 

WHO PQS Immunization Cold Chain Manufacturer Consultation

Author: WHO PQS

Published: 2020

Link: View

 

 

 

Latest jobs

 

Capacity development for WHO guidance dissemination and technical revisions to the current interim WHO publication 'Guidance on operational microplanning for COVID-19 vaccination' - WHO, Remote

Organization: WHO

Location: Remote

Deadline: 20 January 2022

Website: View

Procurement Officer, CDS Grant - PATH, Uganda

Organization: PATH

Location: Uganda

Deadline: 28 February 2022

Website: View

Supply Chain Officer, CDS Grant - PATH, Uganda

Organization: PATH

Location: Uganda

Deadline: 28 February 2022

Website: View

Immunization Officer, NOB (TA) (Nationals only) - UNICEF, India

Organization: UNICEF

Location: India

Deadline: 14 January 2022

Website: View

Roster of Consultants - Clinical and Quality Assessment of vaccines for Prequalification and Emergency Use Listing - WHO, Remote

Organization: WHO

Location: Remote

Deadline: 14 January 2022

Website: View

 

Latest Blogs

 

December 2021 Monthly Update

 

AIRA

 

Best Wishes for the New Year

 

Village Reach

 

Your Gift Helps Close the Vaccine Equity Gap

Only 7% of people in sub-Saharan Africa are fully vaccinated against COVID-19. There is much work ahead to protect people all across the world.

 

Village Reach

 

EYE recruitment: Consultant - international sample transportation (yellow fever)

The EYE Secretariat is recruiting!

 

EYE Strategy

 

 

 

You have received this email because you are signed up to the TechNet-21 Weekly Digest.
Unsubscribe

Reply all
Reply to author
Forward
0 new messages